Co-Formulate Limited (‘Co-Formulate’), a division of Quotient Clinical (‘Quotient’), a leading provider of early stage drug development services, has announced it has been contracted by Proveca Ltd. (Proveca) to perform paediatric formulation development work on several additional off-patent compounds. This agreement follows Co-Formulate’s successful development of an age-appropriate, taste-masked formulation...
Quotient’s CCO Simon Lee elected as Secretary of European CRO Federation
Quotient Clinical (“Quotient”), the innovative provider of early phase drug development services, is pleased to announce that Chief Compliance Officer, Simon Lee, has been elected as Secretary of the European CRO Federation (“EUCROF”). EUCROF is a non-profit organization that promotes clinical research and supports close relationships and the exchange of...
Medilink announces new funding project for Life Science Companies in the South East Midlands
Medilink East Midlands has launched a Life Sciences project that will target Innovative companies in the South East Midlands Local Enterprise Partnership (SEMLEP). Part-funded by the European Regional Development Fund (ERDF), ‘ACTIS’ will provide medical technology, pharmaceutical and bioscience organisations with funding and support to help develop their new innovative...
Exiting the EU: Science and Research
The debate was commenced by The Minister for Universities, Science, Research and Innovation (Joseph Johnson) I beg to move, That this House has considered exiting the EU and science and research. I am pleased to introduce today’s debate about science and research, which is one of a number of debates...
Charnwood Molecular appoints new head of Medicinal Chemistry
Loughborough-based CRO, Charnwood Molecular Ltd, appoints Dr James Hitchin as its new Head of Medicinal Chemistry to lead its research services laboratories at BioCity, Nottingham. Dr Hitchin brings extensive experience from across multiple therapeutic areas in drug discovery to the Charnwood team. James has previously held positions at SAFC Pharma,...
New East Midlands-based export consultancy launches
A new service to help businesses with ambitions to export their goods and services is to be launched in January 2017. Help2Export Ltd, based in Northampton and covering businesses who are based anywhere within the East Midlands is aiming to support those businesses with little or no export experience to...
The BioHub Birmingham hosts national life science event
The BioHub Birmingham®, Birmingham’s flagship life science incubator, is hosting its first BioBrum Life Science event on 16th February 2017. Aimed at pre-revenue life science companies the free event will include talks on finance, intellectual property, effective use of professional networks and business development. There will also be an opportunity...
XenoGesis opens state-of-the-art Bioanalysis suite
Nottingham-based Contract Research Organisation (CRO) XenoGesis has opened a state-of-the-art Bioanalysis suite at BioCity following significant investment in two mass spectrometers, further expanding its bioanalysis capabilities. As part of the continuing commitment to provide the best possible service to its global client base by investing in the latest cutting edge...
Beauty Food Supplements Special Interest Group
The final Food Supplement Special Interest Group meeting of 2016, focussed on beauty, held in the Park Inn by Radisson, Nottingham. Beauty is a strongly emerging category, with sales in the ‘anti-ageing’ market growing by > 7% year on year. The scene was set in the afternoon by Nick Bennett...
XenoGesis Celebrates Fifth Anniversary
BioCity Nottingham-based specialist DMPK Contract Research Organisation (CRO), XenoGesis, marked its 5th anniversary last week with a team celebration. The company’s 5th birthday marks a significant milestone for XenoGesis, which has seen year-on-year growth since its formation in November 2011. XenoGesis was borne out of the closure of AstraZeneca’s Charnwood...
